The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors Conference Program Tuesday October 17, 2017 Hilton Boston Dedham
TABLE OF CONTENTS SECTION PAGE OUR PARTNERS Thank you to exhibitors and sponsors of our first annual Cannabis Conference. 3 CONFERENCE AGENDA 4 PANELS Panel locations, descriptions, and list of speakers. 5-6 SPEAKERS More information on our panelists, moderators and keynote speaker. 7-11 SPONSORS More information on our silver and bronze sponsors. 12-13
A SPECIAL THANK YOU TO OUR PARTNERS EVENT PARTNERS HOST SPONSORS 3
AGENDA REGISTRATION AND NETWORKING BREAKFAST Registration Area, 7:30-8:45am OPENING REMARKS Fairbanks Ballroom, 8:45-9:15am Scott Greiper President and Founder, Viridian Capital Advisors, LLC Scott Moskol Partner & Co-Chair, Cannabis Business Advisory, Burns & Levinson PANEL THE NEW ENGLAND EXPERIENCE Fairbanks Ballroom, 9:15-10:30am James Alex President & COO, Premier Healthcare Group, LLC G. William Eldridge Principle, GW Consulting Jason Sidman Founding Member & CEO, Sanctuary Medicinals, Inc Patricia Rosi CEO, Wellness Connection of Maine Scott Moskol Partner & Co-Chair, Cannabis Business Advisory, Burns & Levinson NETWORKING BREAKOUT SESSION Registration Area, 10:30-10:45am PANEL Follow the Money: Analyzing Capital Flow into the Legal Cannabis Industry Fairbanks Ballroom, 10:45-12pm Kyle Detwiler CEO & Co-Founder, Northern Swan Holdings Jeffrey Finkle Chairman of the Evaluation Committee and Treasurer, ARC Angel Fund Scott Greiper President & Founder, Viridian Capital Advisors, LLC Harrison Phillips -- Vice President, Viridian Capital Advisors, LLC KEYNOTE AND LUNCH Main Ballroom, 12:00-1:30pm Kris Krane Co-Founder & Managing Partner, 4Front Advisors and President, 4Front Ventures NETWORKING B R E A K O U T SESSION Registration Area, 1:30-1:45pm PANEL SECTOR FOCUS: Cannabinoid-Based Biopharmaceuticals and Personalized Medicine Todd Denkin President & COO, Digipath, Inc.* Tamir Gedo, Ph.D. CEO, Breath of Life Pharma, Ltd.* Cindy Orser, Ph.D. Chief Science Officer, Digipath, Inc** Scott Greiper President & Founder, Viridian Capital Advisors, LLC NETWORKING BREAKOUT SESSION PANEL THE FUTURE OF CANNABIS Fairbanks Ballroom, 1:45-2:45 pm Registration Area, 2:45-3:00 pm Main Ballroom, 3:00-4:00 pm G. Ryan Ansin President, Family Office Association Corey Barnette CEO, District Growers, LLC Matthew Darin Co-founder & COO, Grassroots Cannabis Michael Harlow Partner, CohnReznick Nick Kovacevich CEO, Kush Bottles Frank Segall Partner; Chairman, Business Law; Co-Chair, Cannabis Business Advisory, Burns & Levinson NETWORKING RECEPTION
PANELS Panel 1: The New England Experience Time: 9:15 10:30 am Location: Main Ballroom Nationwide, the landscape of the legalized marijuana industry has changed significantly in recent years no place more so than New England. In 2016, Maine and Massachusetts voted to fully legalize cannabis, and Connecticut, New Hampshire, Rhode Island, and Vermont all allow its use for medical purposes. This panel will examine how the industry s laws and regulations have evolved in the region, focusing on the experiences of operators who have navigated the sometimes tempestuous legal waters to guide their businesses to success. James Alex, Premier Healthcare Group, LLC Bill Eldridge, Summit Medical Compassion Center Patricia Rosi, Wellness Connection of Maine Jason Sidman, Sanctuary ATC Moderated by Scott Moskol Burns & Levinson LLP Panel 2: Follow the Money: Analyzing Capital Flow into the Legal Cannabis Industry Time: 10:45 am 12:00 pm Location: Main Ballroom This panel will focus on the capital infusions necessary to launch, operate, or invest in the cannabis space, with Viridian providing deal-data insight regarding capital raises and M&A activity. Additional topics will include valuations and structures, as well as the involvement (or lack thereof) of certain investor types (e.g., traditional VCs, institutional investors, etc.) and strategic acquirers (e.g., big alcohol, big tobacco, etc.). Kyle Detwiler, Northern Swan Holdings Jeffrey Finkle, ARC Angel Fund Scott Greiper, Viridian Capital Advisors Harrison Phillips, Viridian Capital Advisors
PANELS Panel 3: Sector Focus: Cannabinoid-Based Biopharmaceuticals and Personalized Medicine Time: 1:45 2:45 pm Location: Main Ballroom Cannabinoid-based pharmaceuticals and biotechnologies represent a sub-sector of the industry that could hold the greatest potential value over time. This panel will delve deeply into the research, development, and commercialization of cannabis-based pharmaceuticals, as well as the development of the full data chain needed to create effective personalized medicines from the plant. Todd Denkin, Digipath, Inc. Tamir Gedo, Ph.D., Breath of Life Pharma Ltd. Cindy Orser, Ph.D., Digipath, Inc. Moderated by Scott Greiper Viridian Capital Advisors, LLC Panel 4: The Future of Cannabis Time: 3:00 4:00 pm Location: Main Ballroom Cannabis is already a multi-billion dollar industry, and its growth is projected to potentially increase at an exponential and possibly unprecedented rate over the coming years. This panel will explore what the future could hold for legalized marijuana, addressing such topics as legal and regulatory changes at state and federal levels; de- or re-scheduling cannabis under the Controlled Substances Act; changes in interstate and international commerce (i.e., importing/exporting); and shifts in business models (e.g., the need for wholesalers, more centralized processing, an additional focus on biotech/pharma, improvements in quality control, the increased value of big data, etc.). G. Ryan Ansin, Family Office Association Corey Barnette, District Growers, LLC Matthew Darin, Grassroots Cannabis Michael Harlow, CohnReznick Nick Kovacevich, Kush Bottles Moderated by Frank Segall Burns & Levinson LLP
SPEAKERS Kris Krane, Co-founder and President, 4Front Ventures Keynote Speaker 7
8 Stanley.
9
10.
11 changing regulatory environment.
GOLD SPONSOR SILVER SPONSOR 12
BRONZE SPONSORS